API Yield Loss and Solvent Recovery: Reconciling the Weight-Loss Gap

A Chapter 29 API custom-synthesis unit at Hyderabad — the kind of plant that a Tier-2 CRAMS specialist runs against a merchant order book for regulated-market generics developers — closes a batch of a 4-step synthesis to a bulk API. The batch card reads 3.5 tonne of starting material charged at step 1, 2.28 tonne of isolated dried API packed off the drying oven at batch end. The mole-balance yield from starting material through 4 reaction steps to the isolated product molecule is 65 percent actual against a 72 percent theoretical maximum — a 7 percentage-point yield-loss gap that the batch-record review procedure must reconcile against mother-liquor loss, wash-cycle loss, filtration and drying loss, and analytical assay loss. In parallel the reaction solvent leg — 12.0 tonne of hexane charged at HSN 2710, distilled and recovered as 10.4 tonne (87 percent recovery) for the next batch cycle, requiring 1.6 tonne of fresh make-up hexane — must be reconciled through the solvent recovery cycle register. The spent solvent and mother liquor sent to the Common Hazardous Waste Treatment, Storage and Disposal Facility must be logged on the Form 3 waste manifest under the Hazardous and Other Wastes (Management and Transboundary Movement) Rules 2016 and reconciled to the state pollution control board monthly return. And the Chapter 27 solvent input ITC — at 18 percent on the 12.0 tonne fresh hexane charge and on the 1.6 tonne make-up top-up — must be tracked as a distinct line in the plant’s Net ITC composition register, because Notification 09/2022-Central Tax (Rate) dated 13 July 2022 sits over the Chapter 27 leg with an interpretive carve-out that some proper officers apply at Rule 89(5) refund-claim scrutiny. This is API yield loss solvent recovery reconciliation pharma manufacturing at the operating level of a Chapter 29 custom-synthesis unit, and the discipline that separates a defensible batch-close from a variance-and-waste reconciliation cycle that runs weeks late is a batch-level material balance workbook that closes input weight against output weight at the first-review step of the batch record.

Quick reference

The reconciliation in one paragraph

A Chapter 29 API custom-synthesis batch produces a defined mass of isolated dried API at a yield below the theoretical maximum, consumes reaction solvents that are partially recovered via distillation, and generates spent solvent and mother liquor that must be disposed under hazardous waste regulation. Four reconciliation surfaces must close for the batch to be released for finance close and dispatch. First — the batch-level material balance reconciles input weight (starting material + reagents + fresh solvent + make-up solvent) against output weight (isolated API + recovered solvent + spent solvent to waste manifest + quantified unrecovered loss). Second — the yield-loss variance analysis translates the gap between actual and standard yield into a rupee cost variance against the standard costing model. Third — the solvent recovery cycle register reconciles fresh solvent purchase from the vendor invoice against distillation-column recovered solvent from the plant DCS batch record, deriving the make-up solvent requirement arithmetically. Fourth — the hazardous waste manifest under Form 3 of the Hazardous and Other Wastes (Management and Transboundary Movement) Rules 2016 reconciles batch-level spent solvent and mother liquor generation to the state pollution control board monthly return. Overlaid on all four is the Chapter 27 solvent ITC composition line in the plant’s Net ITC pool — the fresh hexane and IPA at 18 percent GST that feeds into the Rule 89(5) refund workbook for the Chapter 29 API output but sits under the shadow of Notification 09/2022-Central Tax (Rate) dated 13 July 2022 at scrutiny.

What the scenario looks like in India — safe illustrative brand persona

Indian Chapter 29 API custom synthesis sits in the CRAMS (Contract Research and Manufacturing Services) and CDMO (Contract Development and Manufacturing Organisation) segment of the pharmaceutical value chain, and the illustrative persona for this article is a Tier-2 custom-synthesis specialist running a multi-block dedicated-and-multipurpose facility at Hyderabad or the Bollaram-Bachupally belt in Telangana, at Vishakhapatnam in Andhra Pradesh, or in one of the Ankleshwar and Vadodara chemical clusters of Gujarat. Publicly listed pharma manufacturers with meaningful Chapter 29 API custom-synthesis or CRAMS exposure include Suven Life Sciences and Suven Pharmaceuticals, Neuland Laboratories, Divi’s Laboratories, Laurus Labs, Piramal Pharma, Aragen Life Sciences (formerly GVK Bio), and Syngene International (the Biocon subsidiary). Divi’s Laboratories runs large-scale Chapter 29 merchant API and custom-synthesis capacity at Choutuppal and Chippada. Laurus Labs runs multi-plant API and formulation capacity in the Vishakhapatnam belt. Neuland Laboratories runs custom-synthesis and merchant-generic API capacity at Bonthapally and Pashamylaram in the Hyderabad belt. Suven Life Sciences runs custom-synthesis operations for global pharma innovators at Suryapet and Jadcherla. The reference persona for the reconciliation this article walks through is a single Chapter 29 API custom-synthesis block producing one API on a 4-step synthesis route against a merchant order book for a regulated-market generics developer — a scale point that is representative of the standing operating model of the players named above and that maps cleanly onto the batch-level reconciliation mechanics that a CRAMS finance controller runs at every batch close.

Custom-synthesis blocks in this segment are typically campaign-run — a defined number of batches back-to-back on a single product before changeover to the next customer’s molecule — which means the batch-level material balance discipline compounds into a campaign-level roll-up that feeds the customer invoice under either a cost-plus contract structure (transparent cost buildup plus agreed margin), a fixed-price contract structure (whole-life quote against agreed deliverables), or a milestone-based contract structure (staged deliverables against staged payment). The yield-loss variance analysis inside the campaign roll-up is central to the cost-plus margin negotiation because the actual yield relative to the quoted-at-tender yield determines whether the contract earns or bleeds against the standard.

The regulatory overlay — Section 54(3), Chapter 27 solvent classification, and the hazardous waste framework

Three regulatory anchors govern the batch-level reconciliation of a Chapter 29 API custom-synthesis unit. Two are indirect-tax anchors carried over from the pharma inverted-duty framework, and one is the environmental compliance anchor for spent-solvent-and-mother-liquor disposal.

Section 54(3) of the Central Goods and Services Tax Act 2017 permits a registered person to claim refund of unutilised input tax credit accumulated on account of the rate of tax on inputs being higher than the rate of tax on output supplies — the inverted duty structure. For a Chapter 29 API custom-synthesis unit whose output is 5 percent Chapter 29 organic chemicals or 5 percent Chapter 30 bulk drug mixtures (post the 22 September 2025 rate reset), and whose input base includes 18 percent Chapter 27 solvents, 18 percent Chapter 39 and 48 packaging, and 5 to 12 percent excipients, the inversion is structural at every tax period. Rule 89(5) of the CGST Rules 2017, as amended by Notification 14/2022-Central Tax dated 5 July 2022, gives the refund formula and requires Net ITC in the numerator to exclude input services and capital goods. The complete Rule 89(5) refund playbook for pharma formulations walks the full workbook — the batch-level material balance in this article feeds directly into the Chapter 27 solvent composition line of that workbook.

Notification 09/2022-Central Tax (Rate) dated 13 July 2022, effective 18 July 2022, invokes clause (ii) of the first proviso to Section 54(3) and bars Section 54(3) refund on output supplies falling under HSN Chapter 15 (edible fats and oils) or HSN Chapter 27 (mineral fuels, mineral oils, products of distillation — the chapter that houses hexane, isopropyl alcohol, methanol, toluene and methyl ethyl ketone). The direct footprint of the notification is on the output side — a Chapter 27 solvent manufacturer cannot claim inverted-duty refund on its own inversion cycle. For a Chapter 29 API manufacturer the output is 5 percent Chapter 29 organic chemicals, so the refund is not directly barred; however, the Chapter 27 solvent input proportion of Net ITC is where field-officer scrutiny concentrates under an interpretive carve-out. The Notification 09/2022 Chapter 27 solvent block for pharma sibling walks the notification’s exact text and the defensible reconciliation stance. The parallel Chapter 15 direct-block mechanic for edible-oil manufacturers is documented in the cross-cluster edible oil Chapter 15 inverted-duty refund blocked article. The recovered solvent leg carries the same ITC treatment as the fresh solvent leg — recovered solvent has already borne its 18 percent GST at the point of original purchase, and only the make-up (fresh) solvent draws a new ITC credit each batch cycle.

The Hazardous and Other Wastes (Management and Transboundary Movement) Rules 2016, notified by the Ministry of Environment, Forest and Climate Change, govern the generation, storage, transport and disposal of hazardous waste in India. A Chapter 29 API custom-synthesis unit generates spent solvent (Category B10 in the waste category schedule), mother liquor and process residues (Category B27), filter cake and distillation still bottoms (other applicable categories per the schedule). The unit must maintain a Form 3 waste manifest at every generation event, store waste in an approved on-site hazardous waste storage area, transport waste under a documented manifest with tracking form to a Common Hazardous Waste Treatment, Storage and Disposal Facility or an authorised recycler, and file monthly and annual returns to the state pollution control board — Maharashtra Pollution Control Board (MPCB) for a Kurkumbh or Ankleshwar plant, Gujarat Pollution Control Board (GPCB) for an Ahmedabad or Vadodara plant, Andhra Pradesh Pollution Control Board (APPCB) for a Vishakhapatnam plant, Telangana State Pollution Control Board (TSPCB) for a Hyderabad plant — all operating under the umbrella framework of the Central Pollution Control Board (CPCB).

A worked example — an illustrative single-batch material balance

Illustrative — the following figures represent the operating pattern of a Chapter 29 API custom-synthesis batch at the scale that Indian CRAMS and merchant API manufacturers run against a merchant order book. Public disclosures do not reveal per-batch material balance in the granularity below; cross-verify against your own plant’s batch record and DCS extracts before action.

A single batch of a Chapter 29 API on a 4-step synthesis route closes at the drying oven with the following material balance:

The yield-loss reconciliation reads: 3.50 tonne of starting material at step 1 could theoretically produce 2.52 tonne of isolated API at 72 percent stoichiometric yield through the 4-step route; actual isolated API is 2.28 tonne, an actual yield of 65 percent. The 7 percentage-point yield-loss gap translates to 0.245 tonne of unrealised API (2.52 minus 2.28). At an illustrative standard-cost API value of Rs 42 lakh per tonne (a mid-range Chapter 29 API standard cost — cross-verify against the specific molecule’s cost card), the unrealised API is Rs 10.3 lakh of unfavourable yield variance per batch that finance must reconcile to the standard costing model.

The solvent recovery cycle for the hexane leg reads: 12.00 tonne of hexane charged at reaction (10.40 tonne recovered from the previous batch cycle plus 1.60 tonne fresh from vendor purchase at 18 percent GST under HSN 2710); 10.40 tonne recovered from this batch’s distillation column at 87 percent recovery; 1.60 tonne net loss to the hazardous waste stream and to fugitive-emission-and-still-bottom loss. The Chapter 27 ITC on the 1.60 tonne fresh hexane purchase for this batch — at an illustrative Rs 65,000 per tonne pre-GST price, that is Rs 1.04 lakh in ITC — feeds into the plant’s Net ITC composition register for the tax period, where it sits as a distinct Chapter 27 solvent line under the Notification 09/2022 field-scrutiny carve-out disclosure. The IPA leg reads similarly: 4.50 tonne charged, 3.90 tonne recovered (87 percent), 0.60 tonne make-up fresh purchase.

The hazardous waste manifest reads: 1.60 tonne spent solvent under Category B10 plus 4.20 tonne mother liquor and process residues under Category B27 — a batch total of 5.80 tonne to the on-site hazardous waste storage, transported under an executed Form 3 manifest with tracking form to the state-approved CHWTSDF. At month-end the aggregate of Form 3 manifest entries for all batches in the tax period must equal the outbound quantity declared in the state pollution control board monthly return.

Common reconciliation breakages

Five breakages recur across Indian Chapter 29 API custom-synthesis units running the batch-level material balance discipline, and each maps to a specific control failure that a batch-record review procedure or an environment compliance audit will surface.

• Solvent recovery percent booked at a fixed assumption rather than measured batch by batch. The most common failure mode is a plant that assumes 87 percent recovery (or whatever the standard is) at the ERP inventory movement level rather than reading the actual distillation-column output from the batch DCS. When actual recovery drifts to 82 percent or 92 percent — for reasons of column efficiency, feed composition, or step-wise concentration — the mismatch produces either an over-stated recovered-solvent inventory (booking recovery higher than actual) or an under-stated recovered-solvent inventory (booking recovery lower than actual), both of which surface as inventory count discrepancies at the next physical count. Reconciliation discipline: the solvent recovery cycle register reads actual recovered quantity from the DCS batch record for every batch, and the make-up solvent requirement is the arithmetic residual.

• Chapter 27 solvent ITC composition not disclosed as a distinct line in the Net ITC pool. A Rule 89(5) refund claim that presents Net ITC as an aggregate — without decomposing the Chapter 27 solvent leg — invites a proper officer challenge on the Notification 09/2022 interpretive carve-out at scrutiny, and forces the finance team to reconstruct the invoice-level solvent register under time pressure to defend the claim. Reconciliation discipline: the Statement 1A annexure discloses the Chapter 27 solvent line explicitly, tying back to the batch-level solvent recovery cycle register. The complete Rule 89(5) pharma formulations playbook walks the exact workbook.

• Hazardous waste manifest quantity mismatch to the pollution control board monthly return. A plant that logs Form 3 batch-level generation events on a spreadsheet or on paper batch records, and separately compiles the monthly pollution control board return from a different tracking system, is highly exposed to a quantity mismatch at reconciliation. The mismatch produces either an under-declared-waste compliance risk (regulatory exposure, potential penalty and consent-to-operate escalation with MPCB, GPCB, APPCB or TSPCB) or an over-declared quantity (financial reconciliation error against the batch material balance). Reconciliation discipline: the Form 3 batch manifest is the source-of-truth register for the pollution board return, with a single ingestion path that eliminates the two-system parallel-tracking risk.

• Yield-loss variance booked to the general ledger without root-cause tag. A batch that closes at a yield below the standard produces an unfavourable variance journal in the cost accounting close — but if the variance is posted as a lump-sum general ledger entry without a root-cause tag (mother-liquor loss, wash-cycle loss, filtration loss, analytical assay loss, or step-wise conversion shortfall), the yield-improvement programme cannot mine the batch-family variance history for actionable improvement themes. Reconciliation discipline: the yield-loss variance is decomposed at the batch record level into the specific loss category and tagged to the variance journal, so the operations team’s quarterly yield-improvement review pulls a variance-by-cause pareto rather than an aggregate variance number.

• Recovered solvent treated as fresh-purchase ITC on re-issue to the process. A plant that re-issues recovered solvent from the on-site storage tank back into the next batch’s reactor and books the re-issue as a fresh purchase with fresh ITC is double-counting the ITC. Recovered solvent has already borne its 18 percent GST at the original vendor purchase; the re-issue is an internal inventory movement and does not carry a fresh ITC credit. Reconciliation discipline: the solvent recovery cycle register tracks recovered-solvent inventory as a distinct sub-inventory line (separate from fresh-purchase inventory) with a nil ITC re-issue treatment, and only the make-up (fresh) solvent purchase carries the ITC credit against the vendor invoice at 18 percent under HSN 2710, 2905, 2909 or 2914 as applicable.

How a reconciliation platform handles this

A purpose-built pharma reconciliation platform ingests the batch DCS or LIMS batch record, the ERP inventory movement register, the vendor invoice register with GST at 18 percent on Chapter 27 solvent purchases, and the Form 3 hazardous waste manifest — and produces a batch-level material balance workbook that closes input weight against output weight at the first-review step of the batch record, computes the yield-loss variance against the standard yield assumption with a decomposed root-cause tag, maintains the solvent recovery cycle register with fresh purchase, recovered quantity and make-up requirement per solvent HSN, and reconciles the batch-manifest waste generation against the state pollution control board monthly return quantity. The platform holds the Chapter 27 solvent ITC composition as a distinct line feeding into the tax-period Net ITC pool for the Rule 89(5) refund workbook, and holds the yield-loss variance history at batch-family granularity for the standing yield-improvement programme review. Match rate improvement of 51 to 88 percent on the batch-level DCS-to-ERP inventory movement reconciliation, combined with an ISO 27001:2022 posture and DPDP Act 2023 aligned data handling, is what makes the platform an infrastructure investment for a Tier-2 CRAMS specialist running a multi-block custom-synthesis facility rather than a spreadsheet substitute.

Cross-cluster bridges and where to read next

The batch-level material balance discipline documented here sits inside the broader Chapter 29 API and formulation reconciliation programme. The API vs formulation HSN 2941, 3003, 3004 reconciliation guide is the Wave A cornerstone for the API classification and inversion-cycle framework — read it first if the four-way HSN split between antibiotics (2941), bulk drug mixtures (3003), formulations (3004) and other Chapter 29 API headings is unfamiliar. The Notification 09/2022 Chapter 27 solvent block for pharma sibling walks the notification’s exact text and the defensible field-scrutiny stance for the solvent leg of Net ITC. For the parallel Chapter 15 direct-block mechanic that edible-oil manufacturers face on the OUTPUT side of the same notification, read the cross-cluster edible oil Chapter 15 inverted-duty refund blocked walkthrough — the underlying statutory mechanic (clause (ii) of the first proviso to Section 54(3)) is identical, and the Ch 15 case shows the direct-block flavour that the pharma Ch 27 case escapes but that the field-scrutiny carve-out approximates.

The methodology framework for building the batch-level reconciliation workbook — mapping every input HSN chapter and every output waste category to a distinct reconciliation surface, holding both the batch-record source-of-truth and the ERP-and-return down-stream reconciliation, and building the yield-loss root-cause tagging into the standing variance journal — sits in Terra Insight’s own reconciliation failure mode analysis pillar and the reconciliation playbook for monthly close operations pillar. The commercial pillar for the pharma sub-cluster is Pharma reconciliation software India; the broader authority for the platform sits at reconciliation software India.

The five FAQs below address the operational questions Indian Chapter 29 API custom-synthesis plant controllers and CRAMS finance leads ask most often when building a standing batch-level material balance discipline against the standard costing model, the solvent recovery cycle register, and the hazardous waste manifest reconciliation.

Terra Insight Editorial Team Reconciliation Infrastructure

Content authored by practitioners with experience at Amazon India, Intuit QuickBooks, and the Tata Group. Meet the team →

Published 15 July 2026

Domain expertise

TDS Reconciliation GST Input Credit Platform Settlements NACH Batch Matching Bank Reconciliation Form 26AS Matching ERP Integrations Enterprise Finance Ops

Reviewed by

NK

Navin Krishnan

Managing Director & Founder — Terra Insight

Ex Amazon India · Intuit QuickBooks · Tata nexarc

ISO 27001:2022 Patent Pending Incorporated 2024